폐활량계 시장 규모, 점유율, 예측 및 동향 분석 : 제품별, 기술별, 용도별, 최종 사용자별 - 세계 예측(-2031년)

Spirometers Market Size, Share, Forecast, & Trends Analysis by Product (Spirometer [Incentive, Professional, Wireless, Handheld, Stationary, USB]) Technology (Volume, Peak Flow) Application (COPD, Asthma, Cystic fibrosis) End User-Global Forecast to 2031

The global spirometers market is projected to reach $1.80 billion by 2031 at a CAGR of 9.2% from 2024 to 2031.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of the spirometers market is driven by the rising incidence of respiratory diseases, technological advancements in spirometers, increasing awareness programs regarding respiratory diseases, and the growing preference for home healthcare. However, the high cost of spirometers and a shortage of skilled professionals restrain the growth of this market.

Furthermore, partnerships & collaborations between market players aimed at advancing spirometers and the rising demand from emerging economies are expected to generate growth opportunities for the players operating in this market. However, the availability of alternative technologies poses a major challenge to market growth.

The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over four years (2021-2024). The key players operating in the global spirometers market are Hill-Rom Holdings, Inc. (U.S.) (a subsidiary of Baxter International Inc. (U.S.)), Schiller Americas Inc. (U.S.), Vyaire Medical, Inc. (U.S.), Koninklijke Philips N.V.(Netherlands), KoKo, LLC (U.S.), Midmark Corporation (U.S.), Geratherm Medical AG (Germany), CHEST M.I., Inc. (Japan), Fukuda Sangyo Co., Ltd. (Japan), ndd Medical Technologies (U.S.), MGC Diagnostics Corporation (U.S.), COSMED srl (Italy), and SIBEL, SAU (Spain).

Among all the products studied in this report, the devices segment is expected to account for the largest share of over 65.2% of the spirometers market. This segment's large market share can be attributed to the increasing approvals of spirometer devices, technological advancements in these devices, and their widespread adoption for monitoring disease progression.

Among all the technologies studied in this report, in 2024, the peak flow measurement segment is expected to account for the largest share of the spirometers market. This segment's large market share can be attributed to the ease of use, portability, and cost-effectiveness of peak flow measurement spirometers. These devices are simpler to operate and require minimal setup compared to volume-based devices.

Among all the applications studied in this report, in 2024, the Chronic Obstructive Pulmonary Disease (COPD) segment is expected to account for the largest share of the spirometers market. This segment's large market share can be attributed to the high burden of chronic obstructive pulmonary disease (COPD). For instance, according to the National Institutes of Health (NIH), in 2022, 300 million people worldwide were diagnosed with COPD.

Among all the end users studied in this report, in 2024, the hospitals & clinics segment is expected to account for the largest share of the spirometers market. This segment's large market share can be attributed to the rising cases of respiratory conditions such as asthma, COPD, and pulmonary fibrosis, leading to a significant number of patient visits to hospitals and clinics. For instance, according to the Australian Bureau of Statistics, in 2022, 2.8 million individuals were reported to have asthma in Australia.

An in-depth analysis of the geographical scenario of the global spirometers market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2024, North America is expected to account for the largest share of over 41.6% of the spirometers market. In the region in 2024, the U.S. is expected to account for the largest share of the spirometers market in North America. The large share of the regional market is attributed to the increasing incidence of respiratory diseases leading to higher hospital admissions, the well-established healthcare sector, and the presence of prominent spirometer companies, such as Hill-Rom Holdings, Inc. (U.S.) and Midmark Corporation (U.S.), in this region.

Scope of the Report:

Spirometers Market Assessment-by Product

• Devices
  • Type
• Incentive Spirometers
• Professional Spirometers
• Digital Peak Flow Meters
• Smart Digital Spirometers
• Other Spirometers
  • Portability
• Table-top/Stationary Spirometers
• Handheld Spirometers
  • Connectivity
• Wireless Spirometers
• USB Spirometers
• Consumables & Accessories
• Software

Note: Other Spirometers include windmill-type spirometers and pneumotachometers.

Spirometers Market Assessment-by Technology

• Volume Measurement
• Peak Flow Measurement

Spirometers Market Assessment-by Application

• Chronic Obstructive Pulmonary Disease (COPD)
• Asthma
• Cystic fibrosis
• Pulmonary fibrosis
• Other Applications Chronic Pain

Note: Other Applications include bronchiectasis, lung cancer, emphysema, and chronic bronchitis.

Spirometers Market Assessment-by End User

• Hospitals & Clinics
• Home Care Settings
• Ambulatory Care Centers

Spirometers Market Assessment-by Geography

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • U.K
  • Italy
  • Spain
  • Switzerland
  • Netherlands
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Australia
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • South Africa
  • Rest of Middle East & Africa

TABLE OF CONTENTS

1. Introduction

• 1.1. Market Definition & Scope
• 1.2. Market Ecosystem
• 1.3. Currency and Limitations
• 1.4. Key Stakeholders

2. Research Methodology

• 2.1. Research Approach
• 2.2. Process of Data Collection & Validation
  • 2.2.1. Secondary Research
  • 2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
• 2.3. Market Sizing and Forecasting
  • 2.3.1. Market Size Estimation Approach
  • 2.3.2. Growth Forecast Approach
  • 2.3.3. Market Share Analysis
• 2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights

• 4.1. Overview
• 4.2. Drivers
  • 4.2.1. Rising Incidence of Respiratory Diseases
  • 4.2.2. Technological Advancements in Spirometers
  • 4.2.3. Increasing Awareness Programs Regarding Respiratory Diseases
  • 4.2.4. Growing Preference for Home Healthcare
• 4.3. Restraints
  • 4.3.1. High Cost of Spirometers
  • 4.3.2. Shortage of Skilled Professionals
• 4.4. Opportunities
  • 4.4.1. Emerging Economies
  • 4.4.2. Partnerships & Collaborations Between Market Players Aimed at Advancing Spirometers
• 4.5. Challenges
  • 4.5.1. Availability of Alternative Technologies
• 4.6. Trends
  • 4.6.1. Emergence of Wearable Spirometer Devices
  • 4.6.2. Integration of Telehealth and Remote Monitoring With Spirometry
• 4.7. Factor Analysis
• 4.8. Regulatory Analysis
• 4.9. Pricing Analysis
• 4.10. Case Studies
• 4.11. Porter's Five Forces Analysis

5. Spirometer Market Assessment-by Product

• 5.1. Overview
• 5.2. Devices
  • 5.2.1. Device Type
    • 5.2.1.1. Incentive Spirometers
    • 5.2.1.2. Professional Spirometers
    • 5.2.1.3. Digital Peak Flow Meters
    • 5.2.1.4. Smart Digital Spirometers
    • 5.2.1.5. Other Devices
  • 5.2.2. Portability
    • 5.2.2.1. Table-Top/Stationary Spirometers
    • 5.2.2.2. Hand-held Spirometers
  • 5.2.3. Connectivity Type
    • 5.2.3.1. Wireless Spirometers
    • 5.2.3.2. USB Spirometers
• 5.3. Consumables & Accessories
• 5.4. Software

6. Spirometer Market Assessment-by Technology

• 6.1. Overview
• 6.2. Peak Flow Measurement
• 6.3. Volume Measurement

7. Spirometer Market Assessment-by Application

• 7.1. Overview
• 7.2. Chronic Obstructive Pulmonary Disease (COPD)
• 7.3. Asthma
• 7.4. Cystic Fibrosis
• 7.5. Pulmonary Fibrosis
• 7.6. Other Applications

8. Spirometer Market Assessment-by End User

• 8.1. Overview
• 8.2. Hospitals & Clinics
• 8.3. Home Care Settings
• 8.4. Ambulatory Care Centers

9. Spirometer Market Assessment-by Geography

• 9.1. Overview
• 9.2. North America
  • 9.2.1. U.S.
  • 9.2.2. Canada
• 9.3. Europe
  • 9.3.1. Germany
  • 9.3.2. France
  • 9.3.3. U.K.
  • 9.3.4. Italy
  • 9.3.5. Spain
  • 9.3.6. Switzerland
  • 9.3.7. Netherlands
  • 9.3.8. Rest of Europe
• 9.4. Asia-Pacific
  • 9.4.1. Japan
  • 9.4.2. China
  • 9.4.3. India
  • 9.4.4. Australia
  • 9.4.5. South Korea
  • 9.4.6. Singapore
  • 9.4.7. Rest of Asia-Pacific
• 9.5. Latin America
  • 9.5.1. Brazil
  • 9.5.2. Mexico
  • 9.5.3. Argentina
  • 9.5.4. Rest of Latin America
• 9.6. Middle East & Africa
  • 9.6.1. UAE
  • 9.6.2. Saudi Arabia
  • 9.6.3. South Africa
  • 9.6.4. Rest of Middle East & Africa

10. Competition Analysis

• 10.1. Overview
• 10.2. Key Growth Strategies
• 10.3. Competitive Benchmarking
• 10.4. Competitive Dashboard
  • 10.4.1. Industry Leaders
  • 10.4.2. Market Differentiators
  • 10.4.3. Vanguards
• 10.4. Emerging Companies
• 10.5. Market Share Analysis/Market Rankings of Key Players (2023)

11. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis*)

• 11.1. Hill-Rom Holdings, Inc. (a subsidiary of Baxter International Inc.)
• 11.2. Schiller Americas Inc.
• 11.3. Vyaire Medical, Inc.
• 11.4. Koninklijke Philips N.V.
• 11.5. KoKo, LLC
• 11.6. Midmark Corporation
• 11.7. Geratherm Medical AG
• 11.8. CHEST M.I., Inc.
• 11.9. Fukuda Sangyo Co., Ltd.
• 11.10. ndd Medical Technologies
• 11.11. MGC Diagnostics Corporation
• 11.12. COSMED srl
• 11.13 SIBEL, SAU

(Note: SWOT analyses of the top 5 companies will be provided.)

12. Appendix

• 12.1. Available Customization
• 12.2. Related Reports